Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
Information source: Hospital Sirio-Libanes
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hepatitis; Hepatocellular Carcinomas
Intervention: Low intensity amplitude-moduled electromagnetic fields (Device)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Hospital Sirio-Libanes Official(s) and/or principal investigator(s): Frederico P Costa, MD, Principal Investigator, Affiliation: Hospital Sirio-Libanes
Summary
The propose of this study is to identification of a group of specific amplitude-modulated
frequencies of low intensity electromagnetic fields that is associated with biofeedback upon
exposure to in patients with hepatitis B carries with or without hepatocellular carcinoma.
Clinical Details
Official title: Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic
Primary outcome: Identification of different group of specific frequencies of modulation in hepatitis B carriers with and without hepatocellular carcinoma associated with biofeedback response
Secondary outcome: Characterization of differences biofeedback response in hepatitis B carriers with and without hepatocellular carcinoma
Detailed description:
Patients will be exposed by different specific amplitude-modulated frequencies of low
intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be
recorded in order to identify biofeedback response. Differences in group of frequencies is
expected in patients with hepatitis B carries with or without hepatocellular carcinoma.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- hepatitis B carriers patients
- hepatitis B carriers patients with hepatocellular cancer patients
Exclusion Criteria:
- other tumor types
- other hepatitis types
Locations and Contacts
Hospital Sírio Libanês, São Paulo 01308-050, Brazil
Additional Information
Results of a phase II study on patients with hepatocellular carcinoma
Starting date: April 2012
Last updated: June 12, 2015
|